Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 10 , ISSUE 2 ( April-June, 2018 ) > List of Articles

RESEARCH ARTICLE

Soluble Growth Stimulation Gene-2 Level on Severe Preeclampsia Patients without and with Complications

Laksmi Maharani, Noroyono Wibowo

Keywords : Preeclampsia, Soluble growth stimulation gene-2, Vascular inflammation

Citation Information : Maharani L, Wibowo N. Soluble Growth Stimulation Gene-2 Level on Severe Preeclampsia Patients without and with Complications. J South Asian Feder Obs Gynae 2018; 10 (2):123-126.

DOI: 10.5005/jp-journals-10006-1573

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2018; The Author(s).


Abstract

Introduction: Preeclampsia becomes the main cause of both maternal and perinatal morbidity and mortality. Growth stimulation gene-2 (ST2) is a protein as sign of vascular inflammation, especially soluble ST2 (sST2). This study aims to determine the sST2 concentration on preeclampsia patients without and with complication. Materials and methods: This analytical observational study using cross-sectional design was conducted at the Polyclinic and Emergency Installation, Department of Obstetrics and Gynecology, Dr. Cipto Mangunkusumo Hospital/Faculty of Medicine, Universitas Indonesia, and Budi Kemuliaan Hospital from August to December 2015. We recruited all pregnant women with normal blood pressure and severe preeclampsia to know the difference between maternal blood sST2 on normal blood pressure, severe preeclampsia without and with complication patients. All statistical analysis was done by Statistical Package for the Social Sciences (SPSS) version 19.0. Results: There were 63 subjects consisting of 23 normal blood pressure pregnant women, 19 preeclampsia without complication, and the other 21 preeclampsia with complication. Kruskal–Wallis test pointed out that there was statistical significance among groups (p < 0.001) and significant result between groups (p < 0.001) in Mann–Whitney test. Post hoc analysis indicated that there were significant differences of sST2 level among three groups. The area under the curve (AUC) of sST2 was 96.1% [p < 0.001; 95% confidence interval (CI) 91.8–100%]. The cut-off of sST2 level in this study was 96 ng/mL with 82% sensitivity and 78% specificity. Conclusion: There is significant difference of blood plasma sST2 level among normal blood pressure and preeclampsia without and with complication group.


PDF Share
  1. Turner JA. Diagnosis and management of pre-eclampsia: an update. Int J Womens Health 2010 Sep;2:327-337.
  2. Koual M, Abbou H, Carbonnel M, Picone O, Ayoubi J-M. Short-term outcome of patients with preeclampsia. Vasc Health Risk Manag 2013 Apr;9:143-148.
  3. Li L, Boussiotis VA. Molecular and functional heterogeneity of T regulatory cells. Clin Immunol 2011 Dec;141(3):244-252.
  4. Birawa AD, Hadisaputro H, Hadijono S. D-dimer levels in pregnant women with severe preeclampsia and nonnotensive in RSUP Dr. Kariadi. Indones J Obstet Gynecol 2009 Apr;33(2):65-79.
  5. Burton GJ, Jauniaux E. Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig 2004 Sep; 11(6):342-352.
  6. Redman CW, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol 2010 Jun;63(6):534-543.
  7. Stampalija T, Chaiworapongsa T, Romero R, Chaemsaithong P, Korzeniewski SJ, Schwartz AG, Ferrazzi EM, Dong Z, Hassan SS. Maternal plasma concentrations of sST2 and angiogenic/ anti-angiogenic factors in preeclampsia. J Matern Fetal Neonatal Med 2013 Sep;26(14):1359-1370.
  8. Granne I, Southcombe JH, Snider JV, Tannetta DS, Child T, Redman CW, Sargent IL. ST2 and IL-33 in pregnancy and pre-eclampsia. PloS One 2011 Sep;6(9):e24463.
  9. Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008. BMC Pregnancy Childbirth 2012 Jun;12(1):47.
  10. Khalil A, Syngelaki A, Maiz N, Zinevich Y, Nicolaides KH. Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol 2013 Dec;42(6):634-643.
  11. Schucker JL, Mercer BM, Audibert F, Lewis RL, Friedman SA, Sibai BM. Serial amniotic fluid index in severe preeclampsia: a poor predictor of adverse outcome. Am J Obstet Gynecol 1996 Oct;175(4 Pt 1):1018-1023.
  12. Magann EF, Chauhan SP, Hitt WC, Dubil EA, Morrison JC. Borderline or marginal amniotic fluid index and peripartum outcomes a review of the literature. J Ultrasound Med 2011 Apr;30(4):523-528.
  13. Caselli C. Inflammation in cardiac disease: focus on Interleukin- 33/ST2 pathway. Inflamm Cell Signal 2014 Jun;1(2):e149.
  14. Southcombe JH, Benton SJ, Hu Y, von Dadelszen P, Child T, Snider JV, Redman CW, Sargent IL, Granne I. Measurement of sST2 is comparable to PlGF in the diagnosis of early-onset pre-eclampsia. Pregnancy Hypertens 2013 Apr;3(2):115-117.
  15. Gojnic M, Petkovic S, Papic M, Mostic T, Jeremic K, Vilendecic Z, Djordjevic S. Plasma albumin level as an indicator of severity of preeclampsia. Clin Exp Obstet Gynecol 2004;31(3): 209-210.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.